Skip to main content
Creating a new NHS England: Health Education England, NHS Digital and NHS England have merged. More about the merger.

Current Chapter

Current chapter – Non-digital pathways

The following conditions cannot be identified using centrally held data and will be identified using a non-digital pathway:

Condition category Description Data used
Haematological diseases People with thalassaemia or rare inherited anaemia with severe cardiac iron overload (T2 * less than 10ms on magnetic resonance imaging) or severe to moderate iron overload (T2 * greater than or equal to 10ms on magnetic resonance imaging) plus an additional co-morbidity of concern (for example, diabetes, chronic liver disease or severe hepatic iron load on MRI) Non-digital pathway
Solid cancer

People who have had cancer resected within 3 months and who received no adjuvant chemotherapy or radiotherapy.

People who have had cancer resected within 3 to 12 months and receiving no adjuvant chemotherapy or radiotherapy are expected to be at less risk (and thus less priority) but still at increased risk compared with the non-cancer populations.

Non-digital pathway
Renal disease

An additional substantial risk factor which would in isolation make them eligible for monoclonals or oral antivirals.

Not been vaccinated prior to transplantation.

Non-digital pathway
Immune mediated inflammatory diseases

People who exhibit uncontrolled or clinically active disease (that is required recent increase in dose or initiation of new immunosuppressive drug or IM steroid injection or course of oral steroids within the 3 months prior to positive PCR).

People who have major organ involvement such as significant kidney, liver or lung inflammation or significantly impaired renal, liver and/or lung function.

Non-digital pathway
Immune deficiency Any person with primary or secondary immunodeficiency receiving, or eligible for, immunoglobulin replacement therapy. Non-digital pathway


Last edited: 16 May 2023 10:44 am